Cargando…

Melanoma predisposition—A limited role for germline BRCA1 and BRCA2 variants

Detalles Bibliográficos
Autores principales:	Adams, David J., Bishop, David Timothy, Robles‐Espinoza, Carla Daniela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	News and Views
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6972687/ https://www.ncbi.nlm.nih.gov/pubmed/31610093 http://dx.doi.org/10.1111/pcmr.12833

Ejemplares similares

Thwarting endogenous stress: BRCA protects against aldehyde toxicity
por: Ray Chaudhuri, Arnab, et al.
Publicado: (2017)

When the RAP (80) fades out, you can hear BRCA1 RING
por: Panagopoulos, Andreas, et al.
Publicado: (2021)

Beating tumour drug resistance: “Lamarckian” induction in the spotlight
por: Robles‐Espinoza, Carla Daniela
Publicado: (2018)

Pathogenic Germline BRCA1/2 Mutations and Familial Predisposition to Gastric Cancer
por: Ichikawa, Hiroshi, et al.
Publicado: (2018)

USP3 controls BRCA1 “foci”
por: Raychaudhuri, Pradip
Publicado: (2014)

BRCA1 in replication
por: LeBrasseur, Nicole
Publicado: (2006)

BRCA1 on the move
por: Short, Ben
Publicado: (2011)

Landscape of germline BRCA1/BRCA2 variants in breast and ovarian cancer in Peru
por: Ferreyra, Yomali, et al.
Publicado: (2023)

Insights into BRCA Cancer Predisposition from Integrated Germline and Somatic Analyses in 7632 Cancers
por: Yost, Shawn, et al.
Publicado: (2019)

Non-Coding Variants in BRCA1 and BRCA2 Genes: Potential Impact on Breast and Ovarian Cancer Predisposition
por: Santana dos Santos, Elizabeth, et al.
Publicado: (2018)

BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers
por: Maxwell, Kara N., et al.
Publicado: (2017)

Management Strategies of Breast Cancer Patients with BRCA1 and BRCA2 Pathogenic Germline Variants
por: Edaily, Sarah, et al.
Publicado: (2022)

The germline mutational landscape of BRCA1 and BRCA2 in Brazil
por: Palmero, Edenir Inêz, et al.
Publicado: (2018)

Desmoplastic melanoma: C>Ts and NF‐κB
por: Rabbie, Roy, et al.
Publicado: (2016)

How to live without BRCA1
por: Leslie, Mitch
Publicado: (2013)

Olaparib and somatic BRCA mutations
por: George, Angela, et al.
Publicado: (2017)

Tumor Testing for Somatic and Germline BRCA1/BRCA2 Variants in Ovarian Cancer Patients in the Context of Strong Founder Effects
por: Peixoto, Ana, et al.
Publicado: (2020)

Germline variants profiling of BRCA1 and BRCA2 in Chinese Hakka breast and ovarian cancer patients
por: Zhang, Yunuo, et al.
Publicado: (2022)

Prevalence of BRCA1 and BRCA2 germline variants in an unselected pancreatic cancer patient cohort in Pakistan
por: Muhammad, Noor, et al.
Publicado: (2023)

BRCA1-BARD1: the importance of being in shape
por: Daza-Martin, Manuel, et al.
Publicado: (2019)

BRCA1 and BRCA2 germline mutation analysis in the Indonesian population
por: Purnomosari, Dewajani, et al.
Publicado: (2007)

BRCA1 touches up microRNAs
por: Leslie, Mitch
Publicado: (2012)

BRCA1: a movement toward cancer prevention
por: Alli, Elizabeth, et al.
Publicado: (2015)

Role of BRCA gene dysfunction in breast and ovarian cancer predisposition
por: Scully, Ralph
Publicado: (2000)

Germline BRCA2 mutations in men with breast cancer.
por: Mavraki, E., et al.
Publicado: (1997)

BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2
por: Cline, Melissa S., et al.
Publicado: (2018)

A Case of Triple-Negative Breast Cancer with Germline Pathogenic Variants in Both BRCA1 and BRCA2
por: Kitahara, Miyuki, et al.
Publicado: (2021)

Controversies and Open Questions in Management of Cancer-Free Carriers of Germline Pathogenic Variants in BRCA1/BRCA2
por: Bernstein-Molho, Rinat, et al.
Publicado: (2022)

The occurrence of germline BRCA1 and BRCA2 sequence alterations in Slovenian population
por: Stegel, Vida, et al.
Publicado: (2011)

Gene Panel Tumor Testing in Ovarian Cancer Patients Significantly Increases the Yield of Clinically Actionable Germline Variants beyond BRCA1/BRCA2
por: Barbosa, Ana, et al.
Publicado: (2020)

Contribution of germline BRCA1 and BRCA2 sequence alterations to breast cancer in Northern India
por: Saxena, Sunita, et al.
Publicado: (2006)

Contribution of BRCA1 and BRCA2 Germline Mutations to Early Algerian Breast Cancer
por: Henouda, Sarra, et al.
Publicado: (2016)

Germline mutations in BRCA1 and BRCA2 in epithelial ovarian cancer patients in Brazil
por: Maistro, Simone, et al.
Publicado: (2016)

Germline BRCA1 and BRCA2 mutations and the risk of bladder or kidney cancer in Poland
por: Złowocka-Perłowska, Elżbieta, et al.
Publicado: (2022)

Prevalence and Spectrum of Germline BRCA1 and BRCA2 Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the Genome
por: Fanale, Daniele, et al.
Publicado: (2021)

MiRNAs prognostic for basal and BRCA1 breast cancer
por: Pal, Bhupinder, et al.
Publicado: (2018)

A population-based analysis of germline BAP1 mutations in melanoma
por: O’Shea, Sally J., et al.
Publicado: (2017)

A role of BRCA1 and BRCA2 germline mutations in breast cancer susceptibility within Sardinian population
por: Palomba, Grazia, et al.
Publicado: (2009)

Switch of FANCL, a key FA-BRCA component, between tumor suppressor and promoter by alternative splicing
por: Yuan, Chengfu, et al.
Publicado: (2012)

Novel germline mutations and unclassified variants of BRCA1 and BRCA2 genes in Chinese women with familial breast/ovarian cancer
por: Cao, Wen-Ming, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0d7l9o00npp4s88j3dkhplq7n8